Julie L Eiseman - JoVE Visualize

Showing results (11-20 of 63) with videos related to

Pageof 7

Sort By:

Bioconjugate Chemistry|May 19, 2005

N-(2-hydroxypropyl)methacrylamide copolymers of a glutathione (GSH)-activated glyoxalase i inhibitor and DNA alkylating agent: synthesis, reaction kinetics with GSH, and in vitro antitumor activitiesZhe-Bin Zheng, Guozhang Zhu, Heekyung Tak, et al.

Molecular Pharmaceutics|March 28, 2013

A cell-targeted photodynamic nanomedicine strategy for head and neck cancersAlyssa Master, Anthony Malamas, Rachna Solanki, et al.

Journal of Pharmacokinetics and Pharmacodynamics|October 6, 2005

Control-relevant modeling of the antitumor effects of 9-nitrocamptothecin in SCID mice bearing HT29 human colon xenograftsJohn M Harrold, Julie L Eiseman, Erin Joseph, et al.

Cancer Chemotherapy and Pharmacology|October 25, 2007

Tumor, tissue, and plasma pharmacokinetic studies and antitumor response studies of docetaxel in combination with 9-nitrocamptothecin in mice bearing SKOV-3 human ovarian xenograftsWilliam C Zamboni, Sandra Strychor, Erin Joseph, et al.

Journal of Medicinal Chemistry|October 9, 2008

Improved synthesis of 6-epi-dictyostatin and antitumor efficacy in mice bearing MDA-MB231 human breast cancer xenograftsJulie L Eiseman, Lihua Bai, Won-Hyuk Jung, et al.

SLAS Discovery : Advancing Life Sciences R & D|December 1, 2018

Implementation of the NCI-60 Human Tumor Cell Line Panel to Screen 2260 Cancer Drug Combinations to Generate >3 Million Data Points Used to Populate a Large Matrix of Anti-Neoplastic Agent Combinations (ALMANAC) DatabaseDavid A Close, Allen Xinwei Wang, Stanton J Kochanek, et al.

Rapid Communications in Mass Spectrometry : RCM|May 26, 2007

Quantitative determination of the cytidine deaminase inhibitor tetrahydrouridine (THU) in mouse plasma by liquid chromatography/electrospray ionization tandem mass spectrometryRobert A Parise, Merrill J Egorin, Julie L Eiseman, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 4, 2008

Modulation of gemcitabine (2',2'-difluoro-2'-deoxycytidine) pharmacokinetics, metabolism, and bioavailability in mice by 3,4,5,6-tetrahydrouridineJan H Beumer, Julie L Eiseman, Robert A Parise, et al.

Cancer Chemotherapy and Pharmacology|November 16, 2014

Plasma pharmacokinetics and tissue and brain distribution of cisplatin in musk shrewsJulie L Eiseman, Jan H Beumer, Lora H Rigatti, et al.

Cancer Chemotherapy and Pharmacology|October 12, 2012

Formation of active products of benzaldehyde dimethane sulfonate (NSC 281612, DMS612) in human blood and plasma and their activity against renal cell carcinoma linesRobert A Parise, Bean N Anyang, Julie L Eiseman, et al.

Pageof 7

Showing results (11-20 of 63) with videos related to

Sort By:

Pageof 7

Bioconjugate Chemistry|May 19, 2005

N-(2-hydroxypropyl)methacrylamide copolymers of a glutathione (GSH)-activated glyoxalase i inhibitor and DNA alkylating agent: synthesis, reaction kinetics with GSH, and in vitro antitumor activitiesZhe-Bin Zheng, Guozhang Zhu, Heekyung Tak, et al.

Molecular Pharmaceutics|March 28, 2013

A cell-targeted photodynamic nanomedicine strategy for head and neck cancersAlyssa Master, Anthony Malamas, Rachna Solanki, et al.

Journal of Pharmacokinetics and Pharmacodynamics|October 6, 2005

Control-relevant modeling of the antitumor effects of 9-nitrocamptothecin in SCID mice bearing HT29 human colon xenograftsJohn M Harrold, Julie L Eiseman, Erin Joseph, et al.

Cancer Chemotherapy and Pharmacology|October 25, 2007

Tumor, tissue, and plasma pharmacokinetic studies and antitumor response studies of docetaxel in combination with 9-nitrocamptothecin in mice bearing SKOV-3 human ovarian xenograftsWilliam C Zamboni, Sandra Strychor, Erin Joseph, et al.

Journal of Medicinal Chemistry|October 9, 2008

Improved synthesis of 6-epi-dictyostatin and antitumor efficacy in mice bearing MDA-MB231 human breast cancer xenograftsJulie L Eiseman, Lihua Bai, Won-Hyuk Jung, et al.

SLAS Discovery : Advancing Life Sciences R & D|December 1, 2018

Implementation of the NCI-60 Human Tumor Cell Line Panel to Screen 2260 Cancer Drug Combinations to Generate >3 Million Data Points Used to Populate a Large Matrix of Anti-Neoplastic Agent Combinations (ALMANAC) DatabaseDavid A Close, Allen Xinwei Wang, Stanton J Kochanek, et al.

Rapid Communications in Mass Spectrometry : RCM|May 26, 2007

Quantitative determination of the cytidine deaminase inhibitor tetrahydrouridine (THU) in mouse plasma by liquid chromatography/electrospray ionization tandem mass spectrometryRobert A Parise, Merrill J Egorin, Julie L Eiseman, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 4, 2008

Modulation of gemcitabine (2',2'-difluoro-2'-deoxycytidine) pharmacokinetics, metabolism, and bioavailability in mice by 3,4,5,6-tetrahydrouridineJan H Beumer, Julie L Eiseman, Robert A Parise, et al.

Cancer Chemotherapy and Pharmacology|November 16, 2014

Plasma pharmacokinetics and tissue and brain distribution of cisplatin in musk shrewsJulie L Eiseman, Jan H Beumer, Lora H Rigatti, et al.

Cancer Chemotherapy and Pharmacology|October 12, 2012

Formation of active products of benzaldehyde dimethane sulfonate (NSC 281612, DMS612) in human blood and plasma and their activity against renal cell carcinoma linesRobert A Parise, Bean N Anyang, Julie L Eiseman, et al.

Pageof 7